4-Substituted-5-iodo-2-benzylthiopyrimidines were prepared effi ciently in three steps. 2-Benzylthiopyrimidine on iodination in presence of base gave 5-iodo-2-benzylthiopyrimidine (1), which on chlorination with excess of POCl 3 furnished 4-chloro-5-iodo-2-benzylthiopyrimidine (2). Reaction of 2 with substituted aromatic amines, 2-aminopyridine and hydrazine hydrate yielded 4-amino-5-iodo-2-benzylthiopyrimidines 3(a-e), (3f) and (3g) respectively. Further, 4-hydrazino-5-iodo-2-benzylthiopyrimidine on condensation with substituted aromatic and heterocyclic aldehydes afforded the corresponding schiff bases 4(a-h). The structure of synthesized compounds have been established by spectral studies and elemental analysis. Synthesized compounds have been screened for antimicrobial activity. Compound 3f exhibited good antifungal activity against A. niger. The compounds 4a, 4c, 4d, 4g and 4h exhibited good antibacterial activity.
Pyrimidine derivatives have proved to be of great importance in exhibiting therapeutic applications [1] . A large number of pyrimidine nucleosides are clinically useful for the control of retroviral infections [2] [3] [4] [5] . One of the important class of anti-herpetic nucleosides is series of 5-substituted uracil nucleosides such as (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVdu) [6] showed specific antivaricella zoster virus (VZV) activity. In view of effect of 5-substitution on the activity of thiouracil, synthesis and antithyroid activity of several 5-substituted pyrimidine derivatives have been reported [7] . In addition, 5-alkyl or 5-aryl-substituted pyrimidine derivatives are useful intermediates in the synthesis of nucleosides [8] . Also, many 5-substituted pyrimidines have shown inhibitory activity against Streptococcus faecalis R growth [9] and some are evaluated as inhibitors of enzymes involved in the pyrimidine catabolism like dihydrouracil dehydrogenase and uridine phosphorylase [10] . Further, 5-iodo substituted pyrimidine analogs are known for their antimicrobial [11] and antiviral activity [12, 13] . Synthesis and biological activities of several compounds derived from pyrimidine analogs were reported from our laboratory [10, 14, 15] . We report herein the synthesis and antimicrobial activities of 4-amino-5-iodo-2-benzylthiopyrimidines (3a-g) and 4-aryl/heteroarylidenehydrazino-5-iodo-2-benzylthiopyrimidines (4a-h).
Melting points were recorded by using ThomasHoover melting point apparatus and were uncorrected. IR spectra in KBr disc were recorded on PerkinElmer-Spectrum-one FT IR spectrophotometer (ν max in cm -1 ) and 1 H NMR in DMSO-d 6 and/or CDCl 3 on amx 400, 400 MHz spectrophotometer using TMS as internal standard (chemical shift in δ ppm). Mass spectra were recorded on a Jeol SX 102 Mass spectrometer using argon/xenon (6kv, 10 mA) as the FAB gas. Purity of the compounds was checked by TLC using silica gel 'G' plates obtained from Whatman Inc, and a fl uorescent indicator. 5-Iodo-2-benzylthiouracil (1) was prepared by following the known literature method [7] .
General procedure for the synthesis of 4-chloro-5-iodo-2-benzylthiopyrimidine (2) is as follows, to a mixture of 5-iodo-2-benzylthiouracil (1) (0.01 mol) and POCl 3 (0.06 mol) was refluxed for 1 h. Excess POCl 3 was distilled under reduced pressure and the reaction mixture was poured into 200 ml of ice cold water. The solid separated was extracted with ether (3 x 100 ml) and the ether extracts were washed with 5% aq. NaHCO 3 solution (3 x 100 ml), followed by water (3 x 100 ml). The antimicrobial activities were performed by cup plate method [14] . The sample was dissolved in DMF at the concentration of 1000 µg/ml. Compounds were screened for antibacterial activity against P. aeruginosa, E. coli, B. subtilis and S. aureus. Antifungal activity was carried out against A. terrus and A. niger under aseptic conditions. Gentamycine and fluconazole were used as standard drug for antibacterial and antifungal activities, respectively. The zone of inhibition was compared with standard drug after 24 h of incubation at 25 0 for antibacterial activity and 48 h at 30 0 for antifungal activity. 2  1000  19  05  15  10  12  11  3a  1000  07  09  10  11  17  17  3b  1000  06  08  12  13  10  10  3c  1000  07  10  10  11  12  11  3d  1000  10  05  14  16  15  13  3e  1000  08  15  11  14  13  12  3f  1000  05  10  09  15  19  14  3g  1000  19  04  10  11  10  10  4a  1000  18  07  13  15  13 IR spectrum of compound 4h shows characteristic absorption of (N-H) at 3380, (C=N) at 1616 cm -1 . 1 H NMR signals are at δ 9.1 (1H, s, Ar-H, pyrimidine), 9.01 (1H, s, NH), 7.85-7.42 (17H, m, Ar-H, N = CH), 4.43 (2H, s, S-CH 2 -Ph). Further compound 4h was confi rmed by mass spectra analysis, the molecular ion peak at 588 (M + ), fragmented ion peak at 495, 293. The physical constant of all the compounds are given in Table 1 .
All the compounds showed poor activity against gram (-)ve bacteria E. coli (Table 2 ). However compound 2 exhibited good antibacterial activity against gram (-) ve bacteria P. aeruginosa and good antifungal activity against both fungal strains A. niger and A. terrus. Compound 3d exhibited good antibacterial activity against gram (+)ve bacteria S. aureus. Compounds 3f exhibited good activity against A. niger. Compounds 4a, 4c and 4d showed good activity against P. aeruginosa. Compounds 4g and 4h exhibited good antibacterial activity against P. aeruginosa, S. aureus and B. subtilis and antifungal activity against both fungal strains. Other compounds have shown poor to moderate antibacterial and antifungal activity as compared to standard gentamycine and fl uconazole.
